Trump to announce an expansion of his discounted-drug website TrumpRx

Former President Donald Trump will announce an expansion of his discounted-drug website, TrumpRx, during a White House healthcare affordability event on Monday. The update aims to increase the number of medications available on the platform, which currently directs users to drugmakers’ websites for purchases and provides pharmacy coupons. Initially launched in February with over 40 drugs, including weight-loss medications like Ozempic and Wegovy, the site has faced skepticism from Democrats, who claim it steers consumers toward costly brand-name options when generics are available. The White House official previewing the announcement described the expansion as part of broader efforts to address rising health costs, a key voter concern ahead of the November midterm elections. Health expenses remain a pressing issue for Americans, particularly after Medicaid cuts and the expiration of enhanced Affordable Care Act subsidies, which have driven up premiums for some. Democratic Sen. Elizabeth Warren criticized TrumpRx as a ‘conduit for Big Pharma,’ arguing it misleads consumers by promoting expensive drugs while cheaper alternatives exist. The site itself does not sell medications but instead facilitates purchases through manufacturer websites and offers pharmacy discounts. Beyond TrumpRx, the Trump administration has pursued other drug pricing strategies, including agreements with 17 major pharmaceutical companies to align U.S. medication prices with those in other developed nations or offer lower costs. The expansion of TrumpRx comes as affordability debates intensify, with health costs shaping political discourse ahead of the midterms. The announcement, first reported by Bloomberg News, underscores the administration’s focus on healthcare as a campaign issue, though critics question the effectiveness of the platform in delivering meaningful savings for consumers.